Enzyme Replacement Therapy in a Patient with Gaucher Disease Type III: A Paradigmatic Case Showing Severe Adverse Reactions Started a Long Time After the Beginning of Treatment

Introduction: There are three recombinant enzymes available for the treatment of Gaucher disease (GD): imiglucerase, velaglucerase alfa, and taliglucerase alfa. Case report: A male GD type III patient, 14 years old, genotype p.L444P/L444, diagnosed at 2 years old. He had been treated with imiglucera...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Vairo, Filippo, Netto, Cristina, Dorneles, Alicia, Mittelstadt, Suzana, Wilke, Matheus, Doneda, Divair, Michelin, Kristiane, Ribeiro, Camila Blos, Quevedo, Amanda, Vieira, Tatiane, Nalin, Tatiele, Lueska, Sônia, Schwartz, Ida Vanessa D.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Springer Berlin Heidelberg 2013
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3755564/
https://ncbi.nlm.nih.gov/pubmed/23430813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2013_214
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk